Who Paid My Doc
Tigertriever 17 Revascularization Device
Device Neurovascular
PDI 07290015107273
General payments
$1,149,203
Research payments
$1,416,408
Through program year 2025, $1,149,203 in general payments and $1,416,408 in research payments were reported against Tigertriever 17 Revascularization Device (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $324,814 | 502 |
| 2025 | Research | $290,426 | 50 |
| 2024 | General | $271,823 | 665 |
| 2024 | Research | $520,583 | 60 |
| 2023 | General | $284,637 | 601 |
| 2023 | Research | $462,194 | 32 |
| 2022 | General | $267,929 | 314 |
| 2022 | Research | $143,205 | 23 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,082 general · 165 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.